Skip to main content
Top
Published in: BMC Health Services Research 1/2023

Open Access 01-12-2023 | Telemedicine | Research

Telemedicine for the management of diabetic patients in a high-complexity Latin American hospital

Authors: Luz Angela Casas, Juliana Alarcón, Alejandra Urbano, Evelyn E. Peña-Zárate, Saveria Sangiovanni, Laura Libreros-Peña, María Fernanda Escobar

Published in: BMC Health Services Research | Issue 1/2023

Login to get access

Abstract

Background

Noncommunicable diseases such as diabetes mellitus (DM) have gained attention worldwide. Latin America experienced a rise in rates of DM. During the COVID-19 pandemic, a telemedicine program was implemented in a quaternary care academic complex in Latin America to continue the follow-up of patients with diabetes.

Objective

The aim of this study is to describe the clinical experience of DM patient management through telemedicine and the HbA1c behavior of patients followed-up through this modality.

Materials and methods

We conducted a retrospective cohort study including all patients with type 1 or 2 diabetes who were treated via telemedicine from March to December 2020. A Wilcoxon statistical test was used to compare the changes in glycosylated hemoglobin between the first teleconsultation and after 6 months of telemedicine follow-up.

Results

A total of 663 patients were included, 17.65% (117) of whom had type 1 diabetes and 82.35% (546) of whom had type 2 diabetes. Patients with both types of diabetes, presented with stable HbA1c values regardless of the length of follow-up.

Conclusion

The use of telemedicine can be a helpful tool for both patients and health care providers to support the continuity of care to maintain acceptable control levels within glycemic control goals.
Literature
2.
go back to reference Harding JL, Pavkov ME, Magliano DJ, Shaw JE, Gregg EW. Global trends in diabetes complications: a review of current evidence. Diabetologia. 2019;62(1):3–16.CrossRef Harding JL, Pavkov ME, Magliano DJ, Shaw JE, Gregg EW. Global trends in diabetes complications: a review of current evidence. Diabetologia. 2019;62(1):3–16.CrossRef
3.
go back to reference American Diabetes Association. Standards of Medical Care in Diabetes—2022 abridged for primary care providers. Clin Diabetes. 2022;40(1):10–38.CrossRef American Diabetes Association. Standards of Medical Care in Diabetes—2022 abridged for primary care providers. Clin Diabetes. 2022;40(1):10–38.CrossRef
4.
go back to reference ElSayed NA, Aleppo G, Aroda VR, Bannuru RR, Brown FM, Bruemmer D et al. 3. Prevention or Delay of Type 2 Diabetes and Associated Comorbidities: Standards of Care in Diabetes—2023. Diabetes Care. 2023;46(Supplement_1):S41-8. ElSayed NA, Aleppo G, Aroda VR, Bannuru RR, Brown FM, Bruemmer D et al. 3. Prevention or Delay of Type 2 Diabetes and Associated Comorbidities: Standards of Care in Diabetes—2023. Diabetes Care. 2023;46(Supplement_1):S41-8.
5.
go back to reference Skyler JS. Effects of Glycemic Control on Diabetes Complications and on the Prevention of Diabetes. Clin Diabetes. 2004;22(4):162–6.CrossRef Skyler JS. Effects of Glycemic Control on Diabetes Complications and on the Prevention of Diabetes. Clin Diabetes. 2004;22(4):162–6.CrossRef
6.
go back to reference Bellazzi R. Telemedicine and Diabetes Management: current Challenges and Future Research directions. J Diabetes Sci Technol. 2008;2(1):98–104.CrossRef Bellazzi R. Telemedicine and Diabetes Management: current Challenges and Future Research directions. J Diabetes Sci Technol. 2008;2(1):98–104.CrossRef
7.
go back to reference Al-Sofiani ME, Alyusuf EY, Alharthi S, Alguwaihes AM, Al-Khalifah R, Alfadda A. Rapid Implementation of a Diabetes Telemedicine Clinic During the Coronavirus Disease 2019 Outbreak: Our Protocol, Experience, and Satisfaction Reports in Saudi Arabia. J Diabetes Sci Technol. 2020;15(2):329–38. Al-Sofiani ME, Alyusuf EY, Alharthi S, Alguwaihes AM, Al-Khalifah R, Alfadda A. Rapid Implementation of a Diabetes Telemedicine Clinic During the Coronavirus Disease 2019 Outbreak: Our Protocol, Experience, and Satisfaction Reports in Saudi Arabia. J Diabetes Sci Technol. 2020;15(2):329–38.
8.
go back to reference Monaghesh E, Hajizadeh A. The role of telehealth during COVID-19 outbreak: a systematic review based on current evidence. BMC Public Health. 2020;20:1193.CrossRef Monaghesh E, Hajizadeh A. The role of telehealth during COVID-19 outbreak: a systematic review based on current evidence. BMC Public Health. 2020;20:1193.CrossRef
9.
go back to reference Blandford A, Wesson J, Amalberti R, AlHazme R, Allwihan R. Opportunities and challenges for telehealth within, and beyond, a pandemic. Lancet Glob Health. 2020;8(11):e1364–5.CrossRef Blandford A, Wesson J, Amalberti R, AlHazme R, Allwihan R. Opportunities and challenges for telehealth within, and beyond, a pandemic. Lancet Glob Health. 2020;8(11):e1364–5.CrossRef
10.
go back to reference Gajarawala SN, Pelkowski JN. Telehealth benefits and barriers. J Nurse Pract. 2021;17(2):218–21.CrossRef Gajarawala SN, Pelkowski JN. Telehealth benefits and barriers. J Nurse Pract. 2021;17(2):218–21.CrossRef
11.
go back to reference Klonoff DC. Telemedicine for Diabetes. J Diabetes Sci Technol. 2015;10(1):3–5. Klonoff DC. Telemedicine for Diabetes. J Diabetes Sci Technol. 2015;10(1):3–5.
12.
go back to reference Mullur RS, Hsiao JS, Mueller K. Telemedicine in Diabetes Care. Am Fam Physician. 2022;105(3):281–8. Mullur RS, Hsiao JS, Mueller K. Telemedicine in Diabetes Care. Am Fam Physician. 2022;105(3):281–8.
13.
go back to reference Anderson A, O’Connell SS, Thomas C, Chimmanamada R. Telehealth Interventions to improve Diabetes Management among Black and hispanic patients: a systematic review and Meta-analysis. J Racial Ethn Health Disparities. 2022;9(6):2375–86.CrossRefPubMedPubMedCentral Anderson A, O’Connell SS, Thomas C, Chimmanamada R. Telehealth Interventions to improve Diabetes Management among Black and hispanic patients: a systematic review and Meta-analysis. J Racial Ethn Health Disparities. 2022;9(6):2375–86.CrossRefPubMedPubMedCentral
14.
go back to reference American Diabetes Association. 3. Prevention or Delay of Type 2 Diabetes: Standards of Medical Care in Diabetes—2020. Diabetes Care. 2019;43(Supplement_1):S32-6. American Diabetes Association. 3. Prevention or Delay of Type 2 Diabetes: Standards of Medical Care in Diabetes—2020. Diabetes Care. 2019;43(Supplement_1):S32-6.
15.
go back to reference American Diabetes Association. 9. Pharmacologic Approaches to Glycemic Treatment: Standards of Medical Care in Diabetes—2020. Diabetes Care. 2019;43(Supplement_1):S98-110. American Diabetes Association. 9. Pharmacologic Approaches to Glycemic Treatment: Standards of Medical Care in Diabetes—2020. Diabetes Care. 2019;43(Supplement_1):S98-110.
16.
go back to reference American Diabetes Association. 4. Comprehensive Medical Evaluation and Assessment of Comorbidities: Standards of Medical Care in Diabetes—2020. Diabetes Care. 2020;43(Supplement_1):S37-47. American Diabetes Association. 4. Comprehensive Medical Evaluation and Assessment of Comorbidities: Standards of Medical Care in Diabetes—2020. Diabetes Care. 2020;43(Supplement_1):S37-47.
17.
go back to reference American Diabetes Association. 5. Facilitating Behavior Change and Well-being to Improve Health Outcomes: Standards of Medical Care in Diabetes—2020. Diabetes Care. 2020;43(Supplement_1):S48-65. American Diabetes Association. 5. Facilitating Behavior Change and Well-being to Improve Health Outcomes: Standards of Medical Care in Diabetes—2020. Diabetes Care. 2020;43(Supplement_1):S48-65.
18.
go back to reference American Diabetes Association. 2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes—2020. Diabetes Care. 2020;43(Supplement_1):S14-31. American Diabetes Association. 2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes—2020. Diabetes Care. 2020;43(Supplement_1):S14-31.
19.
go back to reference American Diabetes Association. 6. Glycemic Targets: Standards of Medical Care in Diabetes—2020. Diabetes Care. 2020;43(Supplement_1):S66-76. American Diabetes Association. 6. Glycemic Targets: Standards of Medical Care in Diabetes—2020. Diabetes Care. 2020;43(Supplement_1):S66-76.
21.
go back to reference Dhediya R, Chadha M, Bhattacharya AD, Godbole S, Godbole S. Role of Telemedicine in Diabetes Management. J Diabetes Sci Technol. 28 de febrero de 2022;19322968221081132. Dhediya R, Chadha M, Bhattacharya AD, Godbole S, Godbole S. Role of Telemedicine in Diabetes Management. J Diabetes Sci Technol. 28 de febrero de 2022;19322968221081132.
22.
go back to reference Ruiz de Adana MS, Alhambra-Expósito MR, Muñoz-Garach A, Gonzalez-Molero I, Colomo N, Torres-Barea I et al. Randomized Study to Evaluate the Impact of Telemedicine Care in Patients With Type 1 Diabetes With Multiple Doses of Insulin and Suboptimal HbA1c in Andalusia (Spain): PLATEDIAN Study. Diabetes Care. 2020;43(2):337–42. Ruiz de Adana MS, Alhambra-Expósito MR, Muñoz-Garach A, Gonzalez-Molero I, Colomo N, Torres-Barea I et al. Randomized Study to Evaluate the Impact of Telemedicine Care in Patients With Type 1 Diabetes With Multiple Doses of Insulin and Suboptimal HbA1c in Andalusia (Spain): PLATEDIAN Study. Diabetes Care. 2020;43(2):337–42.
23.
go back to reference Rasmussen OW, Lauszus F, Loekke M. Telemedicine compared with standard care in type 2 diabetes mellitus: A randomized trial in an outpatient clinic. J Telemed Telecare. 2016;22(6):363–8. Rasmussen OW, Lauszus F, Loekke M. Telemedicine compared with standard care in type 2 diabetes mellitus: A randomized trial in an outpatient clinic. J Telemed Telecare. 2016;22(6):363–8.
24.
go back to reference De Groot J, Wu D, Flynn D, Robertson D, Grant G, Sun J. Efficacy of telemedicine on glycaemic control in patients with type 2 diabetes: A meta-analysis. World J Diabetes. 2021;12(2):170–97. De Groot J, Wu D, Flynn D, Robertson D, Grant G, Sun J. Efficacy of telemedicine on glycaemic control in patients with type 2 diabetes: A meta-analysis. World J Diabetes. 2021;12(2):170–97.
25.
go back to reference Kusuma CF, Aristawidya L, Susanti CP, Kautsar AP. A review of the effectiveness of telemedicine in glycemic control in diabetes mellitus patients. Medicine (Baltimore). 2022;101(48):e32028. Kusuma CF, Aristawidya L, Susanti CP, Kautsar AP. A review of the effectiveness of telemedicine in glycemic control in diabetes mellitus patients. Medicine (Baltimore). 2022;101(48):e32028.
26.
go back to reference Sood A, Watts SA, Johnson JK, Hirth S, Aron DC. Telemedicine consultation for patients with diabetes mellitus: a cluster randomised controlled trial. J Telemed Telecare. 2018;24(6):385–91.CrossRef Sood A, Watts SA, Johnson JK, Hirth S, Aron DC. Telemedicine consultation for patients with diabetes mellitus: a cluster randomised controlled trial. J Telemed Telecare. 2018;24(6):385–91.CrossRef
27.
go back to reference Faruque LI, Wiebe N, Ehteshami-Afshar A, Liu Y, Dianati-Maleki N, Hemmelgarn BR et al. Effect of telemedicine on glycated hemoglobin in diabetes: a systematic review and meta-analysis of randomized trials. CMAJ Can Med Assoc J. 2017;189(9):E341–64. Faruque LI, Wiebe N, Ehteshami-Afshar A, Liu Y, Dianati-Maleki N, Hemmelgarn BR et al. Effect of telemedicine on glycated hemoglobin in diabetes: a systematic review and meta-analysis of randomized trials. CMAJ Can Med Assoc J. 2017;189(9):E341–64.
30.
go back to reference Fountoulakis S, Papanastasiou L, Gryparis A, Markou A, Piaditis G. Impact and duration effect of telemonitoring on HbA1c, BMI and cost in insulin-treated diabetes Mellitus patients with inadequate glycemic control: a randomized controlled study. study. Hormones. 2015;14(4):632–43. Fountoulakis S, Papanastasiou L, Gryparis A, Markou A, Piaditis G. Impact and duration effect of telemonitoring on HbA1c, BMI and cost in insulin-treated diabetes Mellitus patients with inadequate glycemic control: a randomized controlled study. study. Hormones. 2015;14(4):632–43.
31.
go back to reference Jia H, Chuang HC, Wu SS, Wang X, Chumbler NR. Long-term effect of home telehealth services on preventable hospitalization use. J Rehabil Res Dev. 2009;46(5):557.CrossRefPubMed Jia H, Chuang HC, Wu SS, Wang X, Chumbler NR. Long-term effect of home telehealth services on preventable hospitalization use. J Rehabil Res Dev. 2009;46(5):557.CrossRefPubMed
32.
go back to reference Steventon A, Bardsley M, Billings J, Dixon J, Doll H, Hirani S et al. Effect of telehealth on use of secondary care and mortality: findings from the Whole System Demonstrator cluster randomised trial. BMJ. 2012;344:e3874. Steventon A, Bardsley M, Billings J, Dixon J, Doll H, Hirani S et al. Effect of telehealth on use of secondary care and mortality: findings from the Whole System Demonstrator cluster randomised trial. BMJ. 2012;344:e3874.
Metadata
Title
Telemedicine for the management of diabetic patients in a high-complexity Latin American hospital
Authors
Luz Angela Casas
Juliana Alarcón
Alejandra Urbano
Evelyn E. Peña-Zárate
Saveria Sangiovanni
Laura Libreros-Peña
María Fernanda Escobar
Publication date
01-12-2023
Publisher
BioMed Central
Published in
BMC Health Services Research / Issue 1/2023
Electronic ISSN: 1472-6963
DOI
https://doi.org/10.1186/s12913-023-09267-0

Other articles of this Issue 1/2023

BMC Health Services Research 1/2023 Go to the issue